101.
Timeliness of Financial Reporting in the Russian Energy Sector
Number of pages: 15
Posted: 08 May 2006
Working Paper Series
Fayetteville State University - Department of Accounting
Downloads
371
102.
Pharmaceutical Prices and Political Activity
Number of pages: 47
Posted: 19 Sep 2001
Working Paper Series
Massachusetts Institute of Technology (MIT) - Department of Economics and University of California, Berkeley - Economic Analysis & Policy Group
There are 2 versions of this paper
Pharmaceutical Prices and Political Activity
NBER Working Paper No. w8482
Number of pages: 46
Posted: 17 Sep 2001
Last Revised: 24 Oct 2010
Downloads
58
Downloads
370
103.
The Impact of Foreign Direct Investment in Japan: Case Studies of the Automobile, Finance, and Health Care Industries
Hi-Stat Discussion Paper No. 141
Number of pages: 52
Posted: 28 Feb 2006
Working Paper Series
Hitotsubashi University - Institute of Economic Research
Downloads
366
104.
Forensic Economics: An Introduction With Special Emphasis on Price Fixing
Journal of Competition Law & Economics Vol. 4, No. 1 (October 2007): 31-59
Number of pages: 34
Posted: 31 May 2007
Last Revised: 09 Mar 2013
Accepted Paper Series
Purdue University
There are 3 versions of this paper
Forensic Economics: An Introduction With Special Emphasis on Price Fixing
Journal of Competition Law & Economics Vol. 4, No. 1 (October 2007): 31-59
Number of pages: 34
Posted: 31 May 2007
Last Revised: 09 Mar 2013
Downloads
359
Forensic Economics: An Introduction with Special Emphasis on Price Fixing
Journal of Competition Law and Economics, pp. 1-29, 2007
Number of pages: 35
Posted: 13 Mar 2008
Last Revised: 07 Mar 2013
Downloads
213
Forensic Economics: An Introduction with Special Emphasis on Price Fixing
Journal of Competition Law and Economics, Vol. 4, Issue 1, pp. 31-59, 2008
Posted: 14 Jul 2008
Downloads
359
105.
How Many Patents Does It Take To Make a Drug? Follow-On Pharmaceutical Patents and University Licensing
Michigan Telecommunications and Technology Law Review, Vol. 17, p. 299, 2010
Number of pages: 38
Posted: 03 Oct 2010
Last Revised: 28 Jul 2013
Accepted Paper Series
Stanford Law School
Downloads
358
106.
Pharmaceutical Knowledge Governance: A Human Rights Perspective
Journal of Law, Medicine and Ethics, Vol. 41(1), pp. 163-184, 2013
Number of pages: 22
Posted: 05 Mar 2013
Last Revised: 16 Feb 2015
Accepted Paper Series
University of Toronto - Faculty of Law
Downloads
353
107.
First-Mover Advantages Before and After TRIPS: Evidence from the Indian Pharmaceutical Industry
Number of pages: 32
Posted: 30 Sep 2012
Last Revised: 19 Jun 2014
Working Paper Series
Erasmus University Rotterdam (EUR) - Erasmus School of Economics (ESE) and Indian Institute of Management, Ahmedabad
Downloads
352
108.
Good Fences Make Good Neighbors: A Longitudinal Analysis of an Industry Self-Regulatory Institution
Academy of Management Journal, Forthcoming
Number of pages: 53
Posted: 12 Jan 2008
Accepted Paper Series
Rutgers Business School, Newark & New Brunswick and Tuck School of Business at Dartmouth
Downloads
349
109.
Performance Effects of Imitative Entry
Strategic Management Journal, Vol. 29, No. 8, pp. 797-817, 2008
Number of pages: 37
Posted: 10 Dec 2007
Last Revised: 02 Sep 2015
Accepted Paper Series
University of Michigan - Stephen M. Ross School of Business and Arizona State University (ASU) - W. P. Carey School of Business
Downloads
348
110.
Solving the Problem of New Uses
Number of pages: 66
Posted: 10 Oct 2013
Working Paper Series
affiliation not provided to SSRN
Downloads
348
111.
The Great Global Vitamins Conspiracies, 1985-1999
Number of pages: 190
Posted: 17 Apr 2008
Last Revised: 09 Mar 2013
Working Paper Series
Purdue University
Downloads
345
112.
Does Geography Matter for Science-Based Firms? Epistemic Communities and the Geography of Research and Patenting in Biotechnology
Number of pages: 37
Posted: 01 Oct 2003
Working Paper Series
New York University (NYU) - Department of Management and Organizational Behavior
Downloads
343
113.
Contracting for On-Time Delivery in the U.S. Influenza Vaccine Supply Chain
Manufacturing & Service Operations Management, Vol. 18, No. 3, pp. 332–346, Summer 2016
Number of pages: 34
Posted: 20 Nov 2012
Last Revised: 20 Apr 2017
Accepted Paper Series
Johns Hopkins University - Carey Business School, Carnegie Mellon University - Tepper School of Business and Washington University in St. Louis - John M. Olin Business School
Downloads
342
114.
Latin America Cartel Control
Chapter XIV pp. 291-324, in Competition Law and Policy in Latin America, Eleanor M. Fox and D. Daniel Sokol (editors). Oxford: Hart Publishing (July 2009)
Number of pages: 86
Posted: 07 Jul 2008
Last Revised: 09 Mar 2013
Accepted Paper Series
Purdue University
Downloads
339
115.
Patent Protection, Creative Destruction, and Generic Entry in Pharmaceuticals: Evidence from Patent and Pricing Data
Number of pages: 24
Posted: 16 Nov 2006
Working Paper Series
Georgia Institute of Technology - School of Public Policy
Downloads
338
116.
Traditional Chinese Medicine and European Union Law: Cultural Logics, Product Identities, Market Competition, Legal Rechanneling, and the Need for Global Legal and Medical Pluralism
Peking University Law Journal, July 2014, Peking University School of Transnational Law Research Paper No. 15-2
Number of pages: 62
Posted: 09 Dec 2013
Last Revised: 02 Nov 2015
Accepted Paper Series
Peking University School of Transnational Law, Yale University, Law School, Students and Institute of Capital Markets (ICM)
Downloads
328
117.
Generic Entry into a Regulated Pharmaceutical Market
iHEA 2007 6th World Congress: Explorations in Health Economics Paper
Number of pages: 25
Posted: 11 Jun 2007
Working Paper Series
Universitat Pompeu Fabra - Faculty of Economic and Business Sciences, Universitat Pompeu Fabra - Faculty of Economic and Business Sciences and University of Barcelona
Downloads
326
118.
Sharing, Samples, and Generics: An Antitrust Framework
103 Cornell Law Review 1 (2017)
Number of pages: 64
Posted: 04 Jun 2017
Last Revised: 22 Nov 2017
Accepted Paper Series
Rutgers Law School
Downloads
326
119.
Patent Settlements in the Pharmaceutical Industry: An Antitrust Perspective
Dewenter, Haucap, Kehder (eds.), Wettbewerb und Regulierung in Medien, Politik und Märkten, Festschrift zum 65. Geburtstag von Jörn Kruse, Baden-Baden, Nomos, 2013, pp. 385-413
Number of pages: 27
Posted: 12 Jun 2013
Last Revised: 03 May 2016
Accepted Paper Series
University of Marburg, School of Business & Economics and University of Marburg - School of Business & Economics
Downloads
321
120.
Why the 'Scope of the Patent' Test Cannot Solve the Drug Patent Settlement Problem
Stanford Technology Law Review, Vol. 16, No. 1, 2012
Number of pages: 8
Posted: 15 Sep 2012
Accepted Paper Series
Rutgers Law School
Downloads
318
121.
Entry in the ADHD Drugs Market: Welfare Impact of Generics and Me-Toos
Journal of Industrial Economics, 61(2), 339-392, June 2013
Number of pages: 46
Posted: 09 May 2009
Last Revised: 01 Jul 2015
Working Paper Series
University of East Anglia (UEA) - School of Economic and Social Studies and Florida State University
Downloads
317
122.
Parallel Problems: Applying Institutional Corruption Analysis of Congress to Big Pharma
Number of pages: 18
Posted: 15 Jul 2013
Working Paper Series
Harvard University - Edmond J. Safra Center for Ethics
Downloads
315
123.
Pricing and Reimbursement in U.S. Pharmaceutical Markets
HKS Working Paper No. RWP10-039
Number of pages: 77
Posted: 13 Sep 2010
Working Paper Series
Massachusetts Institute of Technology (MIT) - Sloan School of Management and Harvard Medical School; Harvard Kennedy School (HKS)
There are 2 versions of this paper
Pricing and Reimbursement in U.S. Pharmaceutical Markets
HKS Working Paper No. RWP10-039
Number of pages: 77
Posted: 13 Sep 2010
Downloads
313
Pricing and Reimbursement in U.S. Pharmaceutical Markets
NBER Working Paper No. w16297
Number of pages: 76
Posted: 24 Aug 2010
Downloads
97
Downloads
313
124.
Direct-to-Consumer Advertising in Pharmaceutical Markets
CESifo Working Paper Series No. 1493
Number of pages: 45
Posted: 21 Jul 2005
Working Paper Series
Norwegian School of Economics (NHH) - Department of Economics and University of Vienna - Vienna Institute of Demography
Downloads
307
125.
Organizational Scope and Investment: Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms
Number of pages: 47
Posted: 19 Nov 2004
Working Paper Series
Bates White, LLC and Harvard Business School - Finance Unit
There are 2 versions of this paper
Organizational Scope and Investment: Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms
Number of pages: 47
Posted: 19 Nov 2004
Downloads
307
Organizational Scope and Investment: Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms
NBER Working Paper No. w10933
Number of pages: 48
Posted: 14 Dec 2004
Last Revised: 07 Feb 2014
Downloads
85
Downloads
307
126.
Concentrated Announcements on Clustered Data: An Event Study on Biotechnology Stocks
Number of pages: 66
Posted: 21 Jun 2004
Working Paper Series
University of Liège - Department of Financial Management and HEC Liège
There are 2 versions of this paper
Concentrated Announcements on Clustered Data: An Event Study on Biotechnology Stocks
Number of pages: 66
Posted: 21 Jun 2004
Downloads
304
Concentrated Announcements on Clustered Data: An Event Study on Biotechnology Stocks
Financial Management, Vol. 35, No. 1, Spring 2006
Number of pages: 29
Posted: 19 Jun 2006
Downloads
14
Downloads
304
127.
Global Cartels Redux: The Lysine Antitrust Litigation
Number of pages: 39
Posted: 08 Nov 2014
Working Paper Series
Purdue University
Downloads
304
128.
India’s Pharmaceutical Industry: Global Supply Chain and Governance in the Post- COVID-19 World
Number of pages: 29
Posted: 09 Jun 2020
Working Paper Series
Australian National University (ANU) - Australia South Asia Research Centre (ASARC) and ADFA
Downloads
299
129.
Cyclical Market Power
George Mason Law & Economics Research Paper No. 03-17
Number of pages: 47
Posted: 23 Apr 2003
Working Paper Series
University of Illinois College of Law
Downloads
295
130.
Overseas Acquisition Versus Greenfield Foreign Investment Which Internationalization Strategy is Better for Indian Pharmaceutical Enterprises?
ISID Working Paper No. 2006/07
Number of pages: 70
Posted: 02 Dec 2009
Working Paper Series
Central University of Gujarat and affiliation not provided to SSRN
Downloads
295
131.
Pharmaceutical Antitrust: What the Trump Administration Can Do
Concurrences: Competition Law Review 63 (No. 4, 2016)
Number of pages: 3
Posted: 05 Dec 2016
Accepted Paper Series
Rutgers Law School
Downloads
295
132.
Ethics and Law in FDA Decisionmaking
2005 MICH. ST. L. REV. 1135
Number of pages: 63
Posted: 17 Dec 2007
Last Revised: 02 Jun 2013
Accepted Paper Series
University of San Diego: School of Law
Downloads
291
133.
Liberalization, Firm Size and R&D Performance: A Firm Level Study of Indian Pharmaceutical Industry
Journal of Indian School of Political Economy, Vol. 14, No. 4, pp. 647–666, 2003
Number of pages: 30
Posted: 02 Dec 2009
Accepted Paper Series
Central University of Gujarat
Downloads
289
134.
Antitrust in the Pharmaceutical Sector: An Overview of U.S. Case Law
e-Competitions Bulletin, No. 88026, Nov. 2018
Number of pages: 10
Posted: 11 Nov 2018
Accepted Paper Series
Rutgers Law School
Downloads
286
135.
Regulation and Pricing of Pharmaceuticals: Reference Pricing or Price Cap Regulation?
CESifo Working Paper No. 2059
Number of pages: 39
Posted: 20 Jul 2007
Working Paper Series
Norwegian School of Economics (NHH) - Department of Economics, University of Bergen - Department of Economics and University of Bergen - Department of Economics
Downloads
285
136.
Price Discrimination Across Indications in the Pharmaceutical Industry: The Case of Finasteride
Number of pages: 4
Posted: 15 Dec 2005
Working Paper Series
Istanbul Bilgi University - Department of Economics
Downloads
284
137.
The R&D Scenario in the Indian Pharmaceutical Industry
RIS Discussion Paper No. 176
Number of pages: 57
Posted: 01 May 2012
Working Paper Series
Institute for Studies in Industrial Development
Downloads
282
138.
Business Ethics and the Nutraceutical Industry: Prospectus for an Emerging Regime
Number of pages: 17
Posted: 03 Jan 2007
Working Paper Series
University of the West Indies at Mona, Faculty of Law
Downloads
281
139.
Contract Manufacturing and Quality Risk: Theory and Empirical Evidence
Tuck School of Business Working Paper No. 2815520
Number of pages: 35
Posted: 29 Jul 2016
Last Revised: 22 May 2017
Working Paper Series
The Ohio State University - Fisher College of Business, Clemson University and Tuck School of Business at Dartmouth
Downloads
279
140.
Of Patents and Property
Regulation, Vol. 31, No. 4, Winter 2008-2009, Boston Univ. School of Law Working Paper No. 09-18
Number of pages: 11
Posted: 20 Feb 2009
Accepted Paper Series
Technology & Policy Research Initiative, BU School of Law and Boston University - School of Law
Downloads
279
141.
Trans Pacific Partnership Agreement - Public Health and Medicines Policies
NO ORDINARY DEAL - UNMASKING THE TRANS-PACIFIC PARTNERSHIP FREE TRADE AGREEMENT, Ch. 10, pp. 149-162, J. Kelsey, ed., Allen & Unwin, 2010
Number of pages: 16
Posted: 16 Nov 2010
Accepted Paper Series
Australian National University and ANU College of Law
Downloads
278
142.
Data-Generating Patents
Northwestern University Law Review, Vol. 111, pp. 377-437, 2017
Number of pages: 62
Posted: 24 Mar 2016
Last Revised: 10 Mar 2017
Accepted Paper Series
California Western School of Law and University of San Diego School of Law
Downloads
276
143.
Three Challenges for Pharmaceutical Antitrust
59 Santa Clara Law Review 613 (2020) (symposium), Rutgers Law School Research Paper
Number of pages: 25
Posted: 27 Mar 2019
Last Revised: 23 Feb 2020
Accepted Paper Series
Rutgers Law School
Downloads
276
144.
Brief Amici Curiae of 118 Law, Economics, and Business Professors and the American Antitrust Institute in Support of Petitioners
Supreme Court amicus brief in FTC v. Watson, 2013
Number of pages: 62
Posted: 30 Jan 2013
Accepted Paper Series
Rutgers Law School and Stanford Law School
Downloads
274
145.
Between- vs. Within-Patent Competition
Number of pages: 7
Posted: 02 Mar 2004
Accepted Paper Series
University of Chicago and University of Chicago
Downloads
273
146.
Pharmacogenomics, Genetic Tests, and Patent-Based Incentives
Number of pages: 24
Posted: 14 May 2003
Working Paper Series
Boston University - School of Law
Downloads
272
147.
Intellectual Property and Public Health: Meeting the Challenge of Sustainability
Global Health Programme Working Paper No. 7/2011, FSU College of Law, Public Law Research Paper No. 566
Number of pages: 20
Posted: 28 Nov 2011
Working Paper Series
Florida State University - College of Law
Downloads
271
148.
Credence Goods and Market Power: An Econometric Study on the Brazilian Pharmaceutical Industry
IPEA Working Paper No. 846
Number of pages: 78
Posted: 03 Feb 2002
Working Paper Series
Institute of Applied Economic Research (IPEA) - Directory of Macroeconomic Policy & Studies (DIMAC) and Graduate School of Economics - Getulio Vargas Foundation (EPGE/FGV)
Downloads
270
149.
The Private Order of Innovation Networks
Stanford Law Review, 2016, Forthcoming, BYU Law Research Paper No. 15-23
Number of pages: 92
Posted: 29 Oct 2015
Accepted Paper Series
Columbia Law School
Downloads
268
150.
Сборник задач по инженерной биологии (Engineering Biology Problems Book)
Number of pages: 164
Posted: 17 Jan 2017
Last Revised: 25 Apr 2019
Working Paper Series
I.M. Sechenov First Moscow State Medical University
Downloads
268
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.